Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$82.36
-0.36-0.44%
At close: -
$82.30
-0.06-0.08%
After Hours: Mar 21, 6:15 PM EDT
Comments
Loading...
MetLife Analyst Ratings and Price Targets | NYSE:MET | Benzinga
MetLife Inc has a consensus price target of $88.05 based on the ratings of 20 analysts. The high is $109 issued by Morgan Stanley on February 28, 2025. The low is $71 issued by Barclays on November 17, 2023. The 3 most-recent analyst ratings were released by Morgan Stanley, Wells Fargo, and Keefe, Bruyette & Woods on February 28, 2025, February 19, 2025, and February 12, 2025, respectively. With an average price target of $101.33 between Morgan Stanley, Wells Fargo, and Keefe, Bruyette & Woods, there's an implied 23.13% upside for MetLife Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Morgan Stanley
Wells Fargo
Keefe, Bruyette & Woods
Barclays
BMO Capital
1calculated from analyst ratings
Analyst Ratings for MetLife
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 02/28/2025 | Buy Now | 32.45% | Morgan Stanley | Nigel Dally71% | $101 → $109 | Maintains | Overweight | Get Alert |
| 02/19/2025 | Buy Now | 17.87% | Wells Fargo | Elyse Greenspan76% | $92 → $97 | Maintains | Overweight | Get Alert |
| 02/12/2025 | Buy Now | 19.08% | Keefe, Bruyette & Woods | Ryan Krueger72% | $100 → $98 | Maintains | Outperform | Get Alert |
| 02/07/2025 | Buy Now | 15.43% | Barclays | Alex Scott65% | $96 → $95 | Maintains | Overweight | Get Alert |
| 01/23/2025 | Buy Now | 17.87% | BMO Capital | Jack Matten37% | → $97 | Initiates | → Market Perform | Get Alert |
| 01/14/2025 | Buy Now | 11.79% | Wells Fargo | Elyse Greenspan76% | $93 → $92 | Maintains | Overweight | Get Alert |
| 01/07/2025 | Buy Now | 6.93% | JP Morgan | Jimmy Bhullar67% | $86 → $88 | Maintains | Overweight | Get Alert |
| 01/06/2025 | Buy Now | 16.65% | Barclays | Alex Scott65% | $90 → $96 | Maintains | Overweight | Get Alert |
| 11/27/2024 | Buy Now | 20.3% | TD Cowen | Daniel Bergman55% | $97 → $99 | Maintains | Buy | Get Alert |
| 11/05/2024 | Buy Now | 13% | Wells Fargo | Elyse Greenspan76% | $92 → $93 | Maintains | Overweight | Get Alert |
| 10/31/2024 | Buy Now | 9.36% | Barclays | Alex Scott65% | $91 → $90 | Maintains | Overweight | Get Alert |
| 10/10/2024 | Buy Now | 11.79% | Wells Fargo | Elyse Greenspan76% | $86 → $92 | Maintains | Overweight | Get Alert |
| 10/09/2024 | Buy Now | 17.87% | TD Cowen | Daniel Bergman55% | → $97 | Initiates | → Buy | Get Alert |
| 10/02/2024 | Buy Now | 11.79% | Piper Sandler | John Barnidge75% | $85 → $92 | Maintains | Overweight | Get Alert |
| 09/27/2024 | Buy Now | 15.43% | Jefferies | Suneet Kamath77% | $89 → $95 | Maintains | Buy | Get Alert |
| 09/04/2024 | Buy Now | 10.57% | Barclays | Alex Scott65% | → $91 | Initiates | → Overweight | Get Alert |
| 08/19/2024 | Buy Now | 3.28% | Morgan Stanley | Nigel Dally71% | $86 → $85 | Maintains | Overweight | Get Alert |
| 08/12/2024 | Buy Now | 4.5% | Wells Fargo | Elyse Greenspan76% | $85 → $86 | Maintains | Overweight | Get Alert |
| 08/01/2024 | Buy Now | 16.65% | B of A Securities | Joshua Shanker74% | $99 → $96 | Maintains | Buy | Get Alert |
| 07/23/2024 | Buy Now | 8.14% | Citigroup | Michael Ward76% | $83 → $89 | Maintains | Buy | Get Alert |
| 07/18/2024 | Buy Now | 4.5% | Jefferies | Suneet Kamath77% | $83 → $86 | Maintains | Buy | Get Alert |
| 07/10/2024 | Buy Now | 0.85% | Morgan Stanley | Nigel Dally71% | $82 → $83 | Maintains | Overweight | Get Alert |
| 07/08/2024 | Buy Now | 3.28% | Keefe, Bruyette & Woods | Ryan Krueger72% | $86 → $85 | Maintains | Outperform | Get Alert |
| 07/02/2024 | Buy Now | 4.5% | JP Morgan | Jimmy Bhullar67% | $81 → $86 | Maintains | Overweight | Get Alert |
| 06/28/2024 | Buy Now | 0.85% | Jefferies | Suneet Kamath77% | $88 → $83 | Maintains | Buy | Get Alert |
| 05/22/2024 | Buy Now | -2.79% | Argus Research | Kevin Heal62% | $77 → $80 | Maintains | Buy | Get Alert |
| 05/10/2024 | Buy Now | 3.28% | Wells Fargo | Elyse Greenspan76% | $86 → $85 | Maintains | Overweight | Get Alert |
| 05/07/2024 | Buy Now | 4.5% | Keefe, Bruyette & Woods | Ryan Krueger72% | $87 → $86 | Maintains | Outperform | Get Alert |
| 05/06/2024 | Buy Now | -0.36% | Piper Sandler | John Barnidge75% | $85 → $82 | Maintains | Overweight | Get Alert |
| 04/15/2024 | Buy Now | -0.36% | Morgan Stanley | Nigel Dally71% | $80 → $82 | Maintains | Overweight | Get Alert |
| 04/11/2024 | Buy Now | 4.5% | Wells Fargo | Elyse Greenspan76% | $83 → $86 | Maintains | Overweight | Get Alert |
| 04/10/2024 | Buy Now | 5.71% | Keefe, Bruyette & Woods | Ryan Krueger72% | $82 → $87 | Maintains | Outperform | Get Alert |
| 04/05/2024 | Buy Now | 3.28% | Piper Sandler | John Barnidge75% | $74 → $85 | Maintains | Overweight | Get Alert |
| 02/06/2024 | Buy Now | 0.85% | Wells Fargo | Elyse Greenspan76% | $85 → $83 | Maintains | Overweight | Get Alert |
| 02/05/2024 | Buy Now | -0.36% | UBS | Brian Meredith79% | $87 → $82 | Maintains | Buy | Get Alert |
| 01/10/2024 | Buy Now | 5.71% | UBS | Brian Meredith79% | $84 → $87 | Maintains | Buy | Get Alert |
| 01/09/2024 | Buy Now | -2.79% | Goldman Sachs | Alex Scott65% | $70 → $80 | Maintains | Buy | Get Alert |
| 01/08/2024 | Buy Now | -2.79% | Goldman Sachs | Alex Scott65% | → $80 | Upgrade | Neutral → Buy | Get Alert |
| 12/07/2023 | Buy Now | -6.44% | Keefe, Bruyette & Woods | Ryan Krueger72% | $79 → $77 | Maintains | Outperform | Get Alert |
| 11/17/2023 | Buy Now | -13.73% | Barclays | Tracy Benguigui60% | → $71 | Reinstates | → Overweight | Get Alert |
| 11/02/2023 | Buy Now | -2.79% | Morgan Stanley | Nigel Dally71% | $79 → $80 | Maintains | Overweight | Get Alert |
| 10/06/2023 | Buy Now | -0.36% | JP Morgan | Jimmy Bhullar67% | $85 → $82 | Maintains | Overweight | Get Alert |
| 09/14/2023 | Buy Now | -12.51% | Jefferies | Suneet Kamath77% | $58 → $72 | Upgrade | Hold → Buy | Get Alert |
| 08/18/2023 | Buy Now | -4.01% | Morgan Stanley | Nigel Dally71% | $78 → $79 | Maintains | Overweight | Get Alert |
| 08/15/2023 | Buy Now | 0.85% | Wells Fargo | Elyse Greenspan76% | $82 → $83 | Maintains | Overweight | Get Alert |
| 08/14/2023 | Buy Now | -6.44% | Argus Research | Kevin Heal62% | $70 → $77 | Maintains | Buy | Get Alert |
| 08/09/2023 | Buy Now | -1.58% | Citigroup | Michael Ward76% | $76 → $81 | Maintains | Buy | Get Alert |
| 08/04/2023 | Buy Now | -10.08% | RBC Capital | Mark Dwelle82% | $70 → $74 | Maintains | Outperform | Get Alert |
| 08/03/2023 | Buy Now | -5.22% | Morgan Stanley | Nigel Dally71% | $78 → $78 | Reiterates | Overweight → Overweight | Get Alert |
| 07/17/2023 | Buy Now | -0.36% | Wells Fargo | Elyse Greenspan76% | $75 → $82 | Maintains | Overweight | Get Alert |
| 06/15/2023 | Buy Now | -7.65% | Citigroup | Michael Ward76% | $85 → $76 | Maintains | Buy | Get Alert |
| 06/09/2023 | Buy Now | -2.79% | Keefe, Bruyette & Woods | Ryan Krueger72% | $86 → $80 | Reiterates | → Outperform | Get Alert |
| 06/02/2023 | Buy Now | -5.22% | Morgan Stanley | Nigel Dally71% | $80 → $78 | Maintains | Overweight | Get Alert |
| 05/26/2023 | Buy Now | -21.02% | RBC Capital | Mark Dwelle82% | $68 → $65 | Maintains | Outperform | Get Alert |
| 05/26/2023 | Buy Now | -8.87% | Wells Fargo | Elyse Greenspan76% | $72 → $75 | Maintains | Overweight | Get Alert |
| 05/05/2023 | Buy Now | -17.37% | RBC Capital | Mark Dwelle82% | $76 → $68 | Maintains | Outperform | Get Alert |
| 04/20/2023 | Buy Now | -7.65% | RBC Capital | Mark Dwelle82% | $83 → $76 | Maintains | Outperform | Get Alert |
| 04/12/2023 | Buy Now | -4.01% | Barclays | Tracy Benguigui60% | $83 → $79 | Maintains | Overweight | Get Alert |
| 04/12/2023 | Buy Now | -2.79% | Morgan Stanley | Nigel Dally71% | $90 → $80 | Maintains | Overweight | Get Alert |
| 04/05/2023 | Buy Now | -10.08% | Piper Sandler | John Barnidge75% | $82 → $74 | Maintains | Overweight | Get Alert |
| 04/05/2023 | Buy Now | -12.51% | Wells Fargo | Elyse Greenspan76% | $84 → $72 | Maintains | Overweight | Get Alert |
| 04/05/2023 | Buy Now | -21.02% | Goldman Sachs | Alex Scott65% | $79 → $65 | Maintains | Neutral | Get Alert |
| 02/02/2023 | Buy Now | 9.36% | Morgan Stanley | Nigel Dally71% | $88 → $90 | Maintains | Overweight | Get Alert |
| 01/18/2023 | Buy Now | 0.85% | Wells Fargo | Elyse Greenspan76% | $81 → $83 | Maintains | Overweight | Get Alert |
| 01/10/2023 | Buy Now | 6.93% | Morgan Stanley | Nigel Dally71% | $87 → $88 | Maintains | Overweight | Get Alert |
| 01/09/2023 | Buy Now | -5.22% | Goldman Sachs | Alex Scott65% | $80 → $78 | Downgrade | Buy → Neutral | Get Alert |
| 01/06/2023 | Buy Now | -2.79% | JP Morgan | Jimmy Bhullar67% | $77 → $80 | Maintains | Overweight | Get Alert |
| 12/09/2022 | Buy Now | -0.36% | Jefferies | Suneet Kamath77% | $86 → $82 | Downgrade | Buy → Hold | Get Alert |
| 11/17/2022 | Buy Now | 5.71% | Morgan Stanley | Nigel Dally71% | $85 → $87 | Maintains | Overweight | Get Alert |
| 11/03/2022 | Buy Now | -6.44% | JP Morgan | Jimmy Bhullar67% | $74 → $77 | Maintains | Overweight | Get Alert |
| 11/03/2022 | Buy Now | 3.28% | Morgan Stanley | Nigel Dally71% | $83 → $85 | Maintains | Overweight | Get Alert |
| 10/12/2022 | Buy Now | -10.08% | Wells Fargo | Elyse Greenspan76% | $75 → $74 | Maintains | Overweight | Get Alert |
| 09/22/2022 | Buy Now | — | Raymond James | Wilma Burdis68% | — | Initiates | → Market Perform | Get Alert |
| 08/22/2022 | Buy Now | -6.44% | Credit Suisse | Andrew Kligerman71% | $68 → $77 | Maintains | Outperform | Get Alert |
| 08/17/2022 | Buy Now | 0.85% | Morgan Stanley | Nigel Dally71% | $79 → $83 | Maintains | Overweight | Get Alert |
| 08/04/2022 | Buy Now | -4.01% | Morgan Stanley | Nigel Dally71% | $78 → $79 | Maintains | Overweight | Get Alert |
| 07/14/2022 | Buy Now | -8.87% | Barclays | Tracy Benguigui60% | $79 → $75 | Maintains | Overweight | Get Alert |
| 07/06/2022 | Buy Now | -2.79% | Evercore ISI Group | Thomas Gallagher59% | $81 → $80 | Maintains | Outperform | Get Alert |
| 07/06/2022 | Buy Now | -5.22% | Morgan Stanley | Nigel Dally71% | $80 → $78 | Maintains | Overweight | Get Alert |
| 06/23/2022 | Buy Now | -10.08% | Wolfe Research | Michael Zaremski72% | $70 → $74 | Upgrade | Peer Perform → Outperform | Get Alert |
| 05/24/2022 | Buy Now | -6.44% | Citigroup | Michael Ward76% | → $77 | Initiates | → Buy | Get Alert |
| 05/05/2022 | Buy Now | -2.79% | Morgan Stanley | Nigel Dally71% | $79 → $80 | Maintains | Overweight | Get Alert |
| 04/12/2022 | Buy Now | -4.01% | Barclays | Tracy Benguigui60% | $76 → $79 | Maintains | Overweight | Get Alert |
| 04/06/2022 | Buy Now | -2.79% | Piper Sandler | John Barnidge75% | $77 → $80 | Maintains | Overweight | Get Alert |
FAQ
What is the target price for MetLife (MET) stock?
The latest price target for MetLife (NYSE:MET) was reported by Morgan Stanley on February 28, 2025. The analyst firm set a price target for $109.00 expecting MET to rise to within 12 months (a possible 32.45% upside). 33 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for MetLife (MET)?
The latest analyst rating for MetLife (NYSE:MET) was provided by Morgan Stanley, and MetLife maintained their overweight rating.
When was the last upgrade for MetLife (MET)?
The last upgrade for MetLife Inc happened on January 8, 2024 when Goldman Sachs raised their price target to $80. Goldman Sachs previously had a neutral for MetLife Inc.
When was the last downgrade for MetLife (MET)?
The last downgrade for MetLife Inc happened on January 9, 2023 when Goldman Sachs changed their price target from $80 to $78 for MetLife Inc.
When is the next analyst rating going to be posted or updated for MetLife (MET)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of MetLife, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for MetLife was filed on February 28, 2025 so you should expect the next rating to be made available sometime around February 28, 2026.
Is the Analyst Rating MetLife (MET) correct?
While ratings are subjective and will change, the latest MetLife (MET) rating was a maintained with a price target of $101.00 to $109.00. The current price MetLife (MET) is trading at is $82.30, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.